176 related articles for article (PubMed ID: 32758788)
21. Prevalence of drugs in oral fluid from truck drivers in Brazilian highways.
Bombana HS; Gjerde H; Dos Santos MF; Jamt REG; Yonamine M; Rohlfs WJC; Muñoz DR; Leyton V
Forensic Sci Int; 2017 Apr; 273():140-143. PubMed ID: 28273545
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Dräger DrugTest 5000 in a Naturalistic Setting.
Gjerde H; Clausen GB; Andreassen E; Furuhaugen H
J Anal Toxicol; 2018 May; 42(4):248-254. PubMed ID: 29409046
[TBL] [Abstract][Full Text] [Related]
23. Roadside Drug Testing Approaches.
Alhefeiti MA; Barker J; Shah I
Molecules; 2021 May; 26(11):. PubMed ID: 34072538
[TBL] [Abstract][Full Text] [Related]
24. An evaluation of selected oral fluid point-of-collection drug-testing devices.
Crouch DJ; Walsh JM; Flegel R; Cangianelli L; Baudys J; Atkins R
J Anal Toxicol; 2005; 29(4):244-8. PubMed ID: 15975256
[TBL] [Abstract][Full Text] [Related]
25. Detection of Δ
Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
[TBL] [Abstract][Full Text] [Related]
26. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
27. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation.
Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of psychoactive substances, alcohol and illicit drugs, in Spanish drivers: A roadside study in 2015.
Domingo-Salvany A; Herrero MJ; Fernandez B; Perez J; Del Real P; González-Luque JC; de la Torre R
Forensic Sci Int; 2017 Sep; 278():253-259. PubMed ID: 28778032
[TBL] [Abstract][Full Text] [Related]
29. Oral fluid testing for drugs of abuse.
Bosker WM; Huestis MA
Clin Chem; 2009 Nov; 55(11):1910-31. PubMed ID: 19745062
[TBL] [Abstract][Full Text] [Related]
30. Roadside drug testing: An evaluation of the Alere DDS
Rohrig TP; Moore CM; Stephens K; Cooper K; Coulter C; Baird T; Garnier M; Miller S; Tuyay J; Osawa K; Chou J; Nuss C; Collier J; Wittman KC
Drug Test Anal; 2018 Apr; 10(4):663-670. PubMed ID: 28879663
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.
Desrosiers NA; Milman G; Mendu DR; Lee D; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jul; 406(17):4117-28. PubMed ID: 24828976
[TBL] [Abstract][Full Text] [Related]
32. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
33. Use of a newly-developed portable capillary electrophoresis analyser to detect drugs of abuse in oral fluid: A case study.
Saar-Reismaa P; Brilla CA; Leiman K; Kaljurand M; Vaher M; Kulp M; Mazina-Šinkar J
Talanta; 2020 May; 211():120662. PubMed ID: 32070623
[TBL] [Abstract][Full Text] [Related]
34. Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices.
Cohier C; Mégarbane B; Roussel O
J Anal Toxicol; 2017 Jan; 41(1):71-76. PubMed ID: 27681339
[TBL] [Abstract][Full Text] [Related]
35. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
Biermann T; Schwarze B; Zedler B; Betz P
Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
[TBL] [Abstract][Full Text] [Related]
36. New psychoactive substances in oral fluid of French and Belgian drivers in 2016.
Richeval C; Wille SMR; Nachon-Phanithavong M; Samyn N; Allorge D; Gaulier JM
Int J Drug Policy; 2018 Jul; 57():1-3. PubMed ID: 29631107
[TBL] [Abstract][Full Text] [Related]
37. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in whole blood of drivers involved in road accidents.
Pelletti G; Garagnani M; Rossi F; Roffi R; Barone R; Pelotti S
Forensic Sci Int; 2019 Jan; 294():27-33. PubMed ID: 30447484
[TBL] [Abstract][Full Text] [Related]
38. Prescription and illicit psychoactive drugs in oral fluid--LC-MS/MS method development and analysis of samples from Brazilian drivers.
Zancanaro I; Limberger RP; Bohel PO; dos Santos MK; De Boni RB; Pechansky F; Caldas ED
Forensic Sci Int; 2012 Nov; 223(1-3):208-16. PubMed ID: 23000138
[TBL] [Abstract][Full Text] [Related]
39. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers.
Samyn N; De Boeck G; Verstraete AG
J Forensic Sci; 2002 Nov; 47(6):1380-7. PubMed ID: 12455668
[TBL] [Abstract][Full Text] [Related]
40. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Dräger DrugTest.
Laloup M; Del Mar Ramirez Fernandez M; Wood M; De Boeck G; Maes V; Samyn N
Forensic Sci Int; 2006 Sep; 161(2-3):175-9. PubMed ID: 16842950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
